National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) Symptom Evaluation in Multinational Cohorts of Patients with Chronic Prostatitis/Chronic Pelvic Pain Syndrome

Wagenlehner, Florian M. E.; Till, J. W. Olivier van; Magri, Vittorio; Perletti, Gianpaolo; Houbiers, J. G. A.; Weidner, W.; Nickel, J. Curtis

doi:10.1016/j.eururo.2012.10.042

Cited by 114 publications

(96 citation statements)

References 34 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…There is no 'gold standard' for a definitive diagnosis of CP/CPPS, which is typically based on patient history, symptoms and exclusion of Retrospective data indicate that the most prevalent localisation for pain is the perineal region (63% of patients), followed by the testicular, pubic and penile areas [14].Tests for correlations between the NIH-CPSI symptom domains suggest that urogenital pain has a greater impact on QoL than do urinary symptoms [14] IBS has been shown to be present in 22-31% of patients with CBP or CP/CPPS [13,15] and can increase the severity of pain symptoms [13,15,16] Pain on urination, or that increases with urination Pain during or after ejaculation Muscle tenderness or dysfunction in abdominal/pelvic regions Neuropathic pain Functional bowel symptoms (e.g. IBS)…”

Section: Clinical Assessment and Diagnosismentioning

confidence: 99%

Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline

Rees

Abrahams

Doble³

et al. 2015

BJU International

222

185

View full text Add to dashboard Cite

ObjectivesTo improve awareness and recognition of chronic bacterial prostatitis (CBP) and chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) among non-specialists and patients. To provide guidance to healthcare professionals treating patients with CBP and CP/CPPS, in both non-specialist and specialist settings. To promote efficient referral of care between nonspecialists and specialists and the involvement of the multidisciplinary team (MDT). Patients and MethodsThe guideline population were men with CBP or CP/CPPS (persistent or recurrent symptoms and no other urogenital pathology for ≥3 of the previous 6 months). Consensus recommendations for the guidelines were based on a search to identify literature on the diagnosis and management of CBP and CP/CPPS (published between 1999 and February 2014). A Delphi panel process was used where high-quality, published evidence was lacking. ResultsCBP and CP/CPPS can present with a wide range of clinical manifestations. The four main symptom domains are urogenital pain, lower urinary tract symptoms (LUTSvoiding or storage symptoms), psychological issues and sexual dysfunction. Patients should be managed according to their individual symptom pattern. Options for first-line treatment include antibiotics, a-adrenergic antagonists (if voiding LUTS are present) and simple analgesics. Repeated use of antibiotics, such as quinolones, should be avoided if there is no obvious symptomatic benefit from infection control or cultures do not support an infectious cause. Early use of treatments targeting neuropathic pain and/or referral to specialist services should be considered for patients who do not respond to initial measures. An MDT approach (urologists, pain specialists, nurse specialists, specialist physiotherapists, general practitioners, cognitive behavioural therapists/psychologists, and sexual health specialists) is recommended. Patients should be fully informed about the possible underlying causes and treatment options, including an explanation of the chronic pain cycle. ConclusionChronic prostatitis can present with a wide variety of signs and symptoms. Identification of individual symptom patterns and a symptom-based treatment approach are recommended. Further research is required to evaluate management options for CBP and CP/CPPS.

show abstract

Section: Clinical Assessment and Diagnosismentioning

confidence: 99%

Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline

Rees

Abrahams

Doble³

et al. 2015

BJU International

222

185

View full text Add to dashboard Cite

show abstract

“…Men with chronic prostatitis often experience perineal or pelvic pain with or without irritative voiding symptoms [5][6][7]. Prostatitis is also a well-established cause of elevated PSA [8][9][10].…”

Section: Introductionmentioning

confidence: 99%

“…Prostatitis is also a well-established cause of elevated PSA [8][9][10]. According to National Institutes of Health, prostatitis has been classified into four clinical categories: Category I, acute bacterial prostatitis; Category II, chronic bacterial prostatitis; Category III, chronic pelvic pain syndrome either inflammatory (IIIa) or noninflammatory (IIIb); and Category IV, asymptomatic inflammatory prostatitis [5,11]. Previous study from our group has demonstrated that men having both prostatitis and moderate to severe periodontitis have higher PSA levels compared to those having either condition alone [12].…”

Section: Introductionmentioning

confidence: 99%

Periodontal Treatment Improves Prostate Symptoms and Lowers Serum PSA in Men with High PSA and Chronic Periodontitis

Alwithanani¹,

Bissada

Joshi³

et al. 2015

Dentistry

View full text Add to dashboard Cite

show abstract

“…For others it is a pain that occurs after a painful ejaculation evocative of a spermocystitis. In a study conducted in 2013, Wegenlehner F. [15] et al point out that 63% of patients consult for pelvic and perineal pain. We believe that these pains are the result of a series of events, including: infection, inflammation and local disturbance of innervation.…”

Section: Discussionmentioning

confidence: 99%

Clinical, Paraclinical and Therapeutic Aspects of Chronic Prostatitis

Rimtebaye¹,

Sillong²,

Tashkand³

et al. 2017

OJU

View full text Add to dashboard Cite

Aim: Present the clinical and paraclinical aspects of chronic prostatitis and report the management in urology. Methods: We conducted a retrospective descriptive study of 47 patients referred to the urology department from January 2011 to December 2013. Analysed variables were epidemiological (age, marital status, place of residence, occupation, education level, taking stimulants), clinical, paraclinical (CBU, chlamydia, syphilis and HIV serologies, urine culture susceptibility testing, semen analysis, ultrasound of urinary tree, radiographs, RCU, IVU), treatment and results. Results: The mean age was 44.6 years. The main reasons for consultation were dysuria (55.3%), prostatorrhea (29.8%) and sexual asthenia (12.8%). The general condition was satisfactory (80.9%). Purulent drop was objectified in the urethral meatus in 10.6% of cases, and the DRE was painful at 44.68%. Escherichia coli was the main isolated germ (23.4%). In 55.3%, calcification of the prostatic area was objectified to ultrasound of the urinary tract. The RCU had objectified bilharzia in 8.5% of calcifications of the bladder area and 19.14% of urethral stricture. The medical treatment was completed in all patients according to the etiology and complications by an instrumental or surgical treatment, offline or emergency. The outcome was favorable in 25 patients. Symptoms were improved in 12 others and a failure for the ten remaining. Conclusion: Chronic prostatitis is relatively frequent in urology. Clinical manifestations are diverse and varied. Treatment is difficult with a significant failure rate.

show abstract

National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) Symptom Evaluation in Multinational Cohorts of Patients with Chronic Prostatitis/Chronic Pelvic Pain Syndrome

Cited by 114 publications

References 34 publications

Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline

Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline

Periodontal Treatment Improves Prostate Symptoms and Lowers Serum PSA in Men with High PSA and Chronic Periodontitis

Clinical, Paraclinical and Therapeutic Aspects of Chronic Prostatitis

Contact Info

Product

Resources

About